[1] Chinese Pituitary Adenoma Cooperation Group, Neurosurgery Branch of Chinese Medical Association. Expert consensus on diagnosis and treatment of recurrent pituitary adenomas in China (2019)[J]. Zhonghua Yi Xue Za Zhi, 2019, 99:1449-1453.[中国垂体腺瘤协作组, 中华医学会神经外科学分会. 中国复发性垂体腺瘤诊治专家共识(2019)[J]. 中华医学杂志, 2019, 99: 1449-1453.] [2] Molitch ME. Diagnosis and treatment of pituitary adenomas: a review[J]. JAMA, 2017, 317:516-524. [3] Yildirim AE, Sahinoglu M, Ekici I, Cagil E, Karaoglu D, Celik H, Nacar OA, Belen AD. Non-functioning pituitary adenomas are really clinically non-functioning: clinical and endocrinological symptoms and outcomes with endoscopic endonasal treatment[J]? World Neurosurg, 2015, 85:185-192. [4] Nishioka H, Inoshita N, Sano T, Fukuhara N, Yamada S. Correlation between histological subtypes and MRI findings in clinically nonfunctioning pituitary adenomas[J]. Endoc Pathol, 2012, 23:151-156. [5] Li J, Chen Z, Tian L, Zhou C, He MY, Gao Y, Wang S, Zhou F, Shi S, Feng X, Sun N, Liu Z, Skogerboe G, Dong J, Yao R, Zhao Y, Sun J, Zhang B, Yu Y, Shi X, Luo M, Shao K, Li N, Qiu B, Tan F, Chen R, He J. LncRNA profile study reveals a three-lncRNA signature associated with the survival of patients with oesophageal squamous cell carcinoma[J]. Gut, 2014, 63: 1700-1710. [6] Wu JG. The analyses of the clinical efficiency of endoscopic transsphenoidal reoperation for recurrent pituitary adenoma[D]. Urumchi: Xinjiang Medical University, 2019.[吴继国. 复发性垂体瘤内镜下经鼻蝶再次手术的临床疗效分析[D]. 乌鲁木齐:新疆医科大学, 2019.] [7] Chinese Pituitary Adenoma Cooperation Group. Consensus of Chinese pituitary adenoma surgery experts[J]. Zhonghua Yi Xue Za Zhi, 2015, 95:324-329.[中国垂体腺瘤协作组. 中国垂体腺瘤外科治疗专家共识[J]. 中华医学杂志, 2015, 95:324-329.] [8] Lopes MB. The 2017 World Health Organization classification of tumors of the pituitary gland: a summary[J]. Acta Neuropathol, 2017, 134:521-535. [9] Di Maio S, Cavallo LM, Esposito F, Stagno V, Corriero OV, Cappabianca P. Extended endoscopic endonasal approach for selected pituitary adenomas: early experience[J]. J Neurosurg, 2011, 114:345-353. [10] Heringer LC, de Oliveira MF, Rotta JM, Botelho RV. Effect of repeated transsphenoidal surgery in recurrent or residual pituitary adenomas: a systematic review and Meta-analysis[J]. Surg Neurol Int, 2016, 7:14. [11] Rabadán AT, Hernández D, Ruggeri CS. Pituitary tumors: our experience in the prevention of postoperative cerebrospinal fluid leaks after transsphenoidal surgery[J]. J Neurooncol, 2009, 93: 127-131. [12] Negm HM, Al-Mahfoudh R, Pai M, Singh H, Cohen S, Dhandapani S, Anand VK, Schwartz TH. Reoperative endoscopic endonasal surgery for residual or recurrent pituitary adenomas[J]. J Neurosurg, 2017, 127:397-408. [13] Jahangiri A, Wagner J, Han SW, Zygourakis CC, Han SJ, Tran MT, Miller LM, Tom MW, Kunwar S, Blevins LS, Aghi MK. Morbidity of repeat transsphenoidal surgery assessed in more than 1000 operations[J]. J Neurosurg, 2014, 121:67-74. [14] Wang YP, Jia XX, Wang J, Wang LL, Tan YT, Ma DD, Xia HC. Resection of pituitary adenomas by endoscopic and microscopic surgery via transnasal transsphenoidal approach: a comparative analysis[J]. Zhongguo Lin Chuang Shen Jing Wai Ke Za Zhi, 2016, 21:145-146.[王亚平, 贾晓雄, 王珺, 王林林,谭溢涛, 马德得, 夏鹤春. 神经内镜下与显微镜下经鼻蝶入路手术切除垂体腺瘤的疗效对比分析[J]. 中国临床神经外科杂志, 2016, 21:145-146.] [15] Li M, Zhang JD, Qian RJ, Sun Y, Li ZX, Shi XW. Strategy of recurrence after transsphenoidal approach for pituitary adenoma resection[J]. Zhongguo Shi Yong Shen Jing Ji Bing Za Zhi, 2016, 19:89-90.[李明, 张佳栋, 迁荣军, 孙勇, 李治晓, 史锡文. 经鼻蝶入路切除垂体腺瘤术后复发应对策略[J]. 中国实用神经疾病杂志, 2016, 19:89-90.] [16] Wu SX, Zhang GL, Zhang L, Zhang ZZ, Zhao XJ. The clinical efficacy of endoscopic transsphenoidal reoperation for recurrent pituitary tumor[J]. Zhongguo Lin Chuang Xin Yi Xue, 2015, 8: 958-961.[吴升祥, 张国龙, 张磊, 张振洲, 赵贤军. 内镜下经鼻蝶入路二次手术治疗复发垂体瘤245例[J]. 中国临床新医学, 2015, 8:958-961.] [17] Hwang JM, Kim YH, Kim JW, Kim DG, Jung HW, Chung YS. Feasibility of endoscopic endonasal approach for recurrent pituitary adenomas after microscopic trans-sphenoidal approach[J]. J Korean Neurosurg Soc, 2013, 54:317-322. [18] Wang Z. Effect of transnasal sphenoid sinus approach for neuroendoscopic pituitary adenoma on prognosis in elderly patients with pituitary tumor[J]. Zhongguo Shi Yong Shen Jing Ji Bing Za Zhi, 2019, 22:981-987.[王纵. 经鼻孔蝶窦入路神经内镜下垂体瘤切除术对老年垂体瘤患者预后的影响[J]. 中国实用神经疾病杂志, 2019, 22:981-987.] [19] Huang JX, Guo WL, Hu W, Dai LQ, Gu JL. Comparative study of curative effect between neuroendoscopy and microscope via order nasal sphenoid sinus approach of pituitary adenoma resection[J]. Hainan Yi Xue Yuan Xue Bao, 2019, 25:989-993.[黄进兴, 郭文龙, 胡威, 戴利强,古晋亮. 神经内镜及显微镜单鼻孔蝶窦入路垂体瘤切除术的疗效对比研究[J]. 海南医学院学报, 2019, 25:989-993.] [20] Guo-Dong H, Tao J, Ji-Hu Y, Wen-Jian Z, Xie-Jun Z, Jian G, Zhen L, Tai-Peng J, Jian-Jun D, Yong-Zhong G, Wenlan L, Wei-Ping L. Endoscopic versus microscopic transsphenoidal surgery for pituitary tumors[J]. J Craniofac Surg, 2016, 27:E648-655. [21] Alahmadi H, Dehdashti AR, Gentili F. Endoscopic endonasal surgery in recurrent and residual pituitary adenomas after microscopic resection[J]. World Neurosurg, 2012, 77:540-547. |